Apixaban in bridge to transplant and destination LVAD - rationale and study design: the ApixiVAD trial.
Bruno SchneggRicardo DevezaChristopher HaywardPublished in: ESC heart failure (2024)
A positive outcome in the ApixiVAD study would provide the basis for future, larger, pivotal anticoagulation trials in LVAD patients.